DiaMedica Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $-27 | $0 | $0 | $0 |
Gross Profit | -13 | -18 | -3 | -11 |
EBITDA | -9,621 | -8,596 | -8,004 | -8,133 |
EBIT | -9,632 | -8,614 | -8,007 | -8,144 |
Net Income | -8,740 | -8,620 | -7,699 | -7,707 |
Net Change In Cash | -27 | 0 | 0 | 0 |
Free Cash Flow | -7,771 | -6,621 | -7,604 | -7,161 |
Cash | 15,647 | 3,326 | 4,109 | 2,589 |
Basic Shares | 46,980 | 49,630 | 42,957 | 42,843 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -39 | -30 | -25 | |
EBITDA | -34,354 | -26,642 | -21,237 | -13,976 |
EBIT | -34,397 | -26,681 | -21,267 | -14,001 |
Net Income | -32,766 | -24,444 | -19,381 | -13,676 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -29,102 | -22,101 | -18,752 | -11,592 |
Cash | 15,647 | 3,025 | 4,543 | 4,728 |
Basic Shares | 46,980 | 40,404 | 32,566 | 26,443 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.16 |
2025-12-31 | -$0.17 |
2025-09-30 | -$0.17 |
2025-06-30 | -$0.18 |
